FERMENTA BIOTECH LTD.

The investor presentation for Fermenta Biotech Limited for Q1/FY27 reported a revenue of INR 126.2 crore, reflecting a 13% year-over-year decline but flat quarter-over-quarter performance. EBITDA decreased by 39% year-over-year to INR 22.4 crore, while profit after tax fell 56% to INR 9.5 crore. The presentation highlighted a 24% quarter-over-quarter increase in human nutrition revenue, which now constitutes 47% of total revenue, up from 35% a year earlier. However, animal nutrition volumes declined significantly, down 52% quarter-over-quarter. The document noted two key milestones: FSSAI approval for VITADEE Green® and a ranking in India's Great Mid-size Workplaces. Management emphasized the company's strategic focus on innovation and sustainability, aiming to meet evolving health and nutrition demands globally.

The presentation highlighted both growth in certain segments and significant declines in others.